Laddar populära aktier...
· Certest Biotec, S.L. and Circio are collaborating to create and test circVec DNA-LNP formulations for potential therapeutic application...
· Circio selected to present its circVec circular RNA expression platform at the European Society of Cell and Gene Therapy (ESGCT) annual...
· Circio has been selected to present its circVec circular RNA expression platform at the European Society of Cell and Gene Therapy (ESGC...
Oslo, Norway, 26 August 2024 – Circio Holding ASA (OSE: CRNA) will announce its first half-year 2024 results on Thursday 29 August 2024.
NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, A...
Oslo, Norway 26 June 2024 – Circio Holding ASA (OSE: CRNA), a biotechnology company developing next generation circular RNA vector technolog...
· Circio´s position as a pioneering player in the rapidly emerging circular RNA field is being recognized in the industry · Five articl...
· circVec 2.1 DNA vectors have now demonstrated higher and more durable expression vs.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, THE UNITED KINGDOM,...
Circio Holding ASA: Annual Report 2023
Circio announces in vivo proof-of-concept for its circVec circular RNA platform technology and reinforced gene therapy focus
Circio terminates TG01 cancer vaccine license option agreement with IOVaxis in China for non-payment
Circio announces that partner IOVaxis Therapeutics has exercised the option for an exclusive license to mutant RAS cancer vaccine TG01 in Ch...
The TG01 IND application by Circio’s partner IOVaxis Therapeutics has been approved by the Chinese regulatory authorities
Oslo, Norway, 27 February 2024 – Circio Holding ASA (OSE: CRNA) announces that CFO Lubor Gaal is invited as a panel discussant at the 17th A...
The first patient has been dosed in Circio's TG01 triple combination study
Do not miss Circio’s presentation at the BioStock Life Science Spring Summit, today May 30 at 11.
Missa inte Circios presentation under BioStock Life Science Spring Summit, idag den 30 maj kl 11.
Circio, tidigare Targovax, är ett norskt immunterapibolag inom RNA-baserade behandlingar.
Circio, formerly known as Targovax, is a Norwegian immunotherapy company within RNA-based therapeutics.
Redeye: Targovax - Finansierat för att nå nyckelresultat
